Johnson & Johnson, Eli Lilly, Sanofi and Bristol Myers Squibb are suing the federal government over the future of their 340B drug rebate plans. The lawsuits reflect rising tensions among drugmakers, ...

More than three decades ago, Congress created the 340B program to help safety-net hospitals and clinics expand resources and care for underserved communities. By requiring pharmaceutical companies to ...

Last November, Kansans went to the polls in record numbers and helped elect President Trump to make America, and Kansas, ...

The purpose of the U.S. Senate’s 340B Drug Pricing Program bipartisan working group is to advance bipartisan policy solutions to make certain the 340B program can continue to achieve its intended goal ...

Most government support programs provide benefits directly to people, whether it is SNAP (Supplemental Nutritional Assistance Program), TANF (Temporary Assistance for Needy Families), or housing ...

The 340B Drug Pricing Program helps poor states like Kentucky. Bigstock Senate Bill 14 in the ongoing Kentucky legislative session relates to the federal 340B Drug Pricing Program. This program ...

Your recent opinion piece on the 340B drug discount program (December 18, “Drug discount program remains vital to support healthcare services”) provides a somewhat deceptive picture of the 340B ...

Widespread and longstanding abuse of a federal program designed to provide prescription drugs to low-income patients has prompted lawmakers in Minnesota and Michigan to try to rein in the 340B program ...

On April 28, AEI’s Kirsten Axelsen hosted the former North Carolina Department of Health and Human Services Secretary Kody Kinsley; Anthony DiGiorgio of the University of California, San Francisco; ...

Just days and weeks away from key deadlines, the hospital industry’s leading trade organization is still calling for the administration to scrap a one-year pilot of drugmakers’ preferred approach to ...